Vanguard National Trust’s Guardant Health GH Stock Holding History

Vanguard National Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.95K	Hold	53	–	–	﹤0.01%	620
2026 Q1	$4.9K	Buy	+53	New	+$5.32K	﹤0.01%	607

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard National Trust's GH Position: Q2 2026 in Review

Vanguard National Trust held its Guardant Health (GH) position steady in Q2 2026 at 53 shares worth $7.95K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Vanguard National Trust first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 594 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Vanguard National Trust held 53 shares of Guardant Health worth $7.95K as of Q2 2026.
Vanguard National Trust left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #620 holding.
Vanguard National Trust first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
594 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.